| O.1 | Approve Financial Statements and Statutory Reports | For |
| O.2 | Approve Consolidated Financial Statements and Statutory Reports | For |
| O.3 | Approve the Dividend | For |
| O.4 | Authorise the Scrip Dividend | For |
| O.5 | Approve Auditors' Special Report on Related-Party Transactions Mentioning the Absence of New Transactions | For |
| O.6 | Approve Remuneration Policy of Chair of Supervisory Board | Oppose |
| O.7 | Approve Remuneration Policy of Supervisory Board Members | For |
| O.8 | Approve Remuneration Policy of Chair of Management Board | Oppose |
| O.9 | Approve Remuneration Policy of Management Board Members | Oppose |
| O.10 | Approve Compensation Report of Corporate Officers | Abstain |
| O.11 | Approve Compensation of Maurice Levy, Chair of Supervisory Board | Oppose |
| O.12 | Approve Compensation of Arthur Sadoun, Chair of the Management Board | Abstain |
| O.13 | Approve Compensation of Jean-Michel Etienne, Management Board Member | Abstain |
| O.14 | Approve Compensation of Anne-Gabrielle Heilbronner, Management Board Member | Abstain |
| O.15 | Approve Compensation of Steve King, Management Board Member | Abstain |
| O.16 | Reelect Sophie Dulac as Supervisory Board Member | For |
| O.17 | Reelect Thomas H. Glocer as Supervisory Board Member | Oppose |
| O.18 | Reelect Marie-Josee Kravis as Supervisory Board Member | For |
| O.19 | Reelect Andre Kudelski as Supervisory Board Member | For |
| O.20 | Reelect Andre Kudelski as Supervisory Board Member | Oppose |
| E.21 | Authorize Issuance of Equity or Equity-Linked Securities with Preemptive Rights up to Aggregate Nominal Amount of EUR 30 Million | For |
| E.22 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 9 Million | Oppose |
| E.23 | Approve Issue of Shares for Private Placement | Oppose |
| E.24 | Authorise the Board to Increase the Number of Shares Issued in case of Exceptional Demand | Oppose |
| E,25 | Authorize Board to Set Issue Price for 10 Percent Per Year of Issued Capital Pursuant to Issue Authority without Preemptive Rights | Oppose |
| E.26 | Authorize Capitalization of Reserves of Up to EUR 30 Million for Bonus Issue or Increase in Par Value | For |
| E.27 | Authorize Capital Increase of Up to EUR 9 Million for Future Exchange Offers | Oppose |
| E.28 | Authorize Capital Increase of up to 10 Percent of Issued Capital for Contributions in Kind | For |
| E.29 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans | Oppose |
| E.30 | Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees of International Subsidiaries | Oppose |
| E.31 | Amend Articles 6, 7 and 17 of Bylaws to Comply with Legal Changes | For |
| E.32 | Amend Article 13 of Bylaws Re: Employee Representatives | For |
| E.33 | Amend Article 15 of Bylaws Re: Board Members Deliberation via Written Consultation | For |
| O.34 | Authorize Filing of Required Documents/Other Formalities | For |
